Articles
Silver Prices Approach $92 Amid Inflation and Geopolitical Concerns, Echoing 1980 Market Frenzy
Record highs test key resistance with historical parallels raising caution among analysts
Silver prices have escalated to new record levels, nearing $92 per ounce driven by a blend of persistent inflation data and global geopolitical tensio...
Travere Therapeutics Faces Investor Concerns Following FDA Review Extension and Sales Forecast
Stock Prices Decline Amid Regulatory Updates and Mixed Analyst Sentiment
Shares of Travere Therapeutics, Inc. have experienced a notable decrease following an FDA decision to extend the review period for its supplemental Ne...
Consumer Discretionary Stocks Showing Potential for Significant Gains This Month
Examining Undervalued Opportunities in Coursera, Udemy, and ThredUp Based on RSI Metrics
Several consumer discretionary stocks currently displaying oversold conditions present potential investment opportunities. This analysis focuses on th...
BriaCell Therapeutics Shares Tumble Despite Encouraging Breast Cancer Trial Results
After a brief surge fueled by promising trial data, BriaCell Therapeutics experiences a significant stock decline amid a substantial capital raise
Shares of BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in cancer immunotherapies, declined sharply following a ral...
Microsoft Commits to Cover Data Center Energy Costs Amid Rising Local Utility Concerns
Amid federal pressure and local opposition, Microsoft emphasizes responsible energy usage and community engagement in its data center expansion
In response to governmental calls and local community concerns, Microsoft Corporation has pledged to fully bear the electricity costs associated with ...
CME Revises Margin Policies Amid Silver's Rapid Price Surge Towards $100 per Ounce
The Chicago Mercantile Exchange adjusts margin requirements to reflect silver's accelerating price rally driven by supply deficits and geopolitical factors
The Chicago Mercantile Exchange (CME) has altered its margin calculation methodology for precious metals futures, switching from fixed dollar margins ...
BP Stock Dips Amid Fourth-Quarter Trading Update Highlighting Production and Pricing Pressures
Energy giant forecasts steady upstream output but flags challenging price realizations and impairment charges ahead of Q4 2025 earnings
Shares of BP p.l.c. declined in premarket trading following the release of a trading update outlining expectations for the fourth quarter of 2025. The...
Mobileye Is a Growth Story Mispriced: Buy the AI-Driving Leader at ~10.7
Strong revenue runway, healthy cash generation and a fortress balance sheet — trading below book and well off 2025 highs.
Mobileye (MBLY) is a leader in ADAS and autonomous driving software/hardware that is growing revenue while investing heavily in R&D. Recent quarters s...
Buy FactSet (FDS) on Growth Re-acceleration: Cheap Relative to Its Earnings Run-Rate
Stable cash flow, improving revenue trajectory, modest yield and a reasonable P/E make FDS an asymmetric long for patient traders.
FactSet looks attractively priced after a pullback: TTM revenue ~ $2.33B, TTM diluted EPS ~ $15.7 and a trailing P/E around 18.6 on the latest close. ...
Broadcom Upgrade: Buy the XPU Optionality — Growth-Adjusted Multiples Now Compelling
Large revenue base, healthy margins, and AI-tailwinds justify a tactical long — entry 340–360, stop 315, targets 420 / 480
Broadcom is positioned as a large-scale AI and infrastructure supplier with consistent ~15B quarterly revenue, strong operating cash flow, and expandi...
WeRide Integrates Robotaxi Booking into Tencent's WeChat to Broaden Autonomous Ride Access
The new 'WeRide Go' Mini Program enables seamless Robotaxi reservations within China's leading social app, marking an important step toward commercial-scale self-driving taxi services
WeRide Inc. has introduced its Robotaxi booking platform as a Mini Program within Tencent's WeChat app, allowing users in select Chinese regions to re...
Revvity Reports Positive Q4 and 2025 Fiscal Year Forecasts Amid Market Headwinds
Life sciences firm anticipates revenue growth and beats earnings guidance while stock exhibits short-term momentum
Revvity, Inc. (NYSE:RVTY) saw its stock climb following preliminary financial results for Q4 and fiscal year 2025 that indicate steady revenue growth ...